IQAIF (Imaging Biometrics) FCF Margin %: 8.16% (As of Dec. 2025)


What is Imaging Biometrics FCF Margin %?

Imaging Biometrics IQAIF FCF Margin % is 8.16% as of Dec. 2025. The stock has 3 warning signs investors should review. Among 669 Healthcare Providers & Services companies, Imaging Biometrics ranks worse than 82.36% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Imaging Biometrics's Free Cash Flow for the six months ended in Dec. 2025 was $0.04 Mil. Imaging Biometrics's Revenue for the six months ended in Dec. 2025 was $0.53 Mil. Therefore, Imaging Biometrics's FCF Margin % for the quarter that ended in Dec. 2025 was 8.16%.

As of today, Imaging Biometrics's current FCF Yield % is -10.94%.

The historical rank and industry rank for Imaging Biometrics's FCF Margin % or its related term are showing as below:

IQAIF' s FCF Margin % Range Over the Past 10 Years
Min: -434.55   Med: -71.92   Max: -24.11
Current: -24.2

During the past 13 years, the highest FCF Margin % of Imaging Biometrics was -24.11%. The lowest was -434.55%. And the median was -71.92%.

IQAIF's FCF Margin % is ranked worse than
82.36% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 3.39 vs IQAIF: -24.20

Imaging Biometrics FCF Margin % Related Terms

Imaging Biometrics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Imaging Biometrics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imaging Biometrics FCF Margin % Chart

Imaging Biometrics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -66.38 -77.49 -28.79 -59.39 -24.08

Imaging Biometrics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.89 -70.44 -43.41 -56.07 8.16

IQAIF vs VEEV, BTSG, TEM: FCF Margin % Comparison

For the Health Information Services subindustry, Imaging Biometrics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imaging Biometrics FCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Imaging Biometrics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Imaging Biometrics's FCF Margin % falls into.


Imaging Biometrics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Imaging Biometrics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.254/1.055
=-24.08 %

Imaging Biometrics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.043/0.527
=8.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 8.16% mean?
Imaging Biometrics (IQAIF) has a FCF Margin % of 8.16% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Imaging Biometrics and its competitors. According to the industry distribution chart, Imaging Biometrics ranks #551 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 82.4%.
Is Imaging Biometrics' FCF Margin % too high?
Imaging Biometrics' current FCF Margin % is 8.16%. The Healthcare Providers & Services industry median FCF Margin % is 3.39. Imaging Biometrics' value of 8.16% is 140.7% above this industry median. Based on the distribution chart, Imaging Biometrics ranks #551 out of 669 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Imaging Biometrics' FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Imaging Biometrics ranks #551 out of 669 companies for FCF Margin %. This places Imaging Biometrics in the lower half of its industry. The industry median FCF Margin % is 3.39. Imaging Biometrics' value of 8.16% is 140.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.39, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Imaging Biometrics's current FCF Margin % of 8.16% is 140.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Imaging Biometrics and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Imaging Biometrics's current FCF Margin % is 8.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imaging Biometrics stock overvalued right now?
Imaging Biometrics (IQAIF) has a current FCF Margin % of 8.16%. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 33.3% below its estimated fair value. The current FCF Margin % is 8.16% and 140.7% above the Healthcare Providers & Services industry median of 3.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Imaging Biometrics (IQAIF), the current FCF Margin % is 8.16% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imaging Biometrics Business Description

Other Exchanges IBAI:UK
Address IFC 5, Channel Islands, Saint Helier, JEY, JE1 1ST
Imaging Biometrics Ltd formerly, IQ-AI Ltd operates as an investment company. The principal activity of the group is the provision of convenient, cost-effective, and clinical treatments to patients in the field of medical imaging diagnostics, based on technologies. Its geographical segment includes United Kingdom, Switzerland, European Union, and the United States of America and reportable segments are holding company expenses, medical software, Oral GaM and organ-on-a-chip. The company derives a majority of its revenue from the United States of America. It also supplies medical technology solutions and has a neuroimaging product portfolio.